End-eXpiratory Occlusion Test to Predict fluId REsponsiveness in the Operating Room (EXPIRE) (EXPIRE)

August 24, 2021 updated by: University Hospital, Clermont-Ferrand

End-eXpiratory Occlusion Test to Predict fluId REsponsiveness in the Operating Room: Prospective Randomized Clinical Trial Comparing Two Occlusion Tests (EXPIRE)

The purpose of the study is to evaluate the influence of different durations of the end-expiratory occlusion test to predict fluid responsiveness in mechanically ventilated patients in the operating room.

Study Overview

Detailed Description

The reduction of postoperative complications is an essential aspect of care in perioperative medicine.

Many studies have shown that individualized hemodynamic therapy, by optimizing fluid administration and cardiac output, can reduce the risk of postoperative morbidity and mortality.

A fluid challenge, consisting in the administration of a small bolus of intravenous volume of fluid over a short period of time, is one of the commonest therapeutic hemodynamic intervention to test the preload reserve and the cardiac response to an increase in intravascular volume of a patient (fluid responsiveness). However, an increase in stroke volume (or cardiac output) is only achieved in 30 to 50% of patients after a fluid challenge test. Several dynamic tests have been described to predict the response to fluid challenge, however their limits are numerous.

The end-expiratory occlusion (EEO) test, consisting in a brief interruption of mechanical ventilation at end-expiration, by preventing the variation in intra-thoracic pressure, allows an increase in venous return, cardiac preload and stroke volume. Thus, an increase in stroke volume during an EEO can predict fluid responsiveness, simulating a fluid challenge though avoiding the administration of possibly unnecessary fluids.

The EEO test has already been successfully evaluated in several studies in ICU patients. Only few studies were conducted in the operating room, with conflicting findings: one study, consisting of an EEO test of 30 seconds found that changes in stroke volume during an EEO can predict fluid responsiveness, whereas another one, consisting of an EEO test of 15 seconds did not.

The purpose of the study is to evaluate the influence of the duration of EEO test to predict fluid responsiveness in mechanically ventilated patients in operating room.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France
        • CHU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults (age >18 years)
  • Scheduled to undergo planned surgery under general anesthesia
  • Surgery requiring invasive arterial and stroke volume monitoring
  • Clinical indication to perform a fluid challenge
  • Patients able to give informed consent
  • Affiliated to a social security scheme

Exclusion Criteria:

  • Patient refusal to participate or inability to provide informed consent
  • Protected major
  • History of lobectomy or pneumectomy
  • Patient with reduced left (ejection fraction < 45%) or right ventricular systolic function
  • Arrythmia
  • Severe valvulopathy
  • Body Mass Index <15 or > 40kg/m2
  • Contraindication to insertion of invasive arterial line into radial artery
  • Emergency surgery
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Group A
The EEO test will be applied first over 15 seconds and secondly over 30 seconds (each EEO test separated by 1 minute wash-out period)

A set of respiratory and hemodynamic measurements (including cardiac output) will be recorded at each stage:

  • T0: baseline.
  • T1: At the end of the first EEO (15 sec or 30 sec)
  • T2: 1 minute after completion of the first EEO. Return to baseline.
  • T3: At the end of the second EEO (15 sec or 30 sec)
  • T4: 1 minute after completion of the second EEO. Return to baseline.
  • T5: Before the fluid challenge test (4 ml/kg of 0.9% saline over 5 min)
  • T6: 1 minute after the end of the fluid challenge

A first set of measurements will be performed after intubation (before the surgical incision) and will be repeated, if necessary, in case of further decrease in stroke volume during surgery or in case of any clinical indication of volume expansion (i.e., arterial persistent hypotension, major hemorrhage, etc.).

Other: Group B
The EEO test will be applied first over 30 seconds and secondly over 15 seconds (each EEO test separated by 1 minute wash-out period)

A set of respiratory and hemodynamic measurements (including cardiac output) will be recorded at each stage:

  • T0: baseline.
  • T1: At the end of the first EEO (15 sec or 30 sec)
  • T2: 1 minute after completion of the first EEO. Return to baseline.
  • T3: At the end of the second EEO (15 sec or 30 sec)
  • T4: 1 minute after completion of the second EEO. Return to baseline.
  • T5: Before the fluid challenge test (4 ml/kg of 0.9% saline over 5 min)
  • T6: 1 minute after the end of the fluid challenge

A first set of measurements will be performed after intubation (before the surgical incision) and will be repeated, if necessary, in case of further decrease in stroke volume during surgery or in case of any clinical indication of volume expansion (i.e., arterial persistent hypotension, major hemorrhage, etc.).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare the ability of an EEO over 30 sec with that of an EEO over 15 sec to predict fluid responsiveness
Time Frame: During surgery
Comparison of the areas under the ROC (Receiver Operating Characteristic) curves.
During surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Emmanuel Futier, PhD, University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 3, 2020

Primary Completion (Actual)

March 24, 2021

Study Completion (Actual)

March 24, 2021

Study Registration Dates

First Submitted

May 19, 2020

First Submitted That Met QC Criteria

May 19, 2020

First Posted (Actual)

May 22, 2020

Study Record Updates

Last Update Posted (Actual)

August 25, 2021

Last Update Submitted That Met QC Criteria

August 24, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Diagnostic Test: end-expiratory occlusion (EEO) test

3
Subscribe